Content deleted Content added
→Interactions: at least some language correction, please double check Tags: Mobile edit Mobile web edit |
→Inhibitors: clean up |
||
Line 58:
==Inhibitors==
Fasentin is a small molecule inhibitor of the intracellular domain of GLUT1 preventing glucose uptake.<ref name="pmid19001437">{{cite journal | vauthors = Wood TE, Dalili S, Simpson CD, Hurren R, Mao X, Saiz FS, Gronda M, Eberhard Y, Minden MD, Bilan PJ, Klip A, Batey RA, Schimmer AD | title = A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death | journal = Molecular Cancer Therapeutics | volume = 7 | issue = 11 | pages = 3546–55 | date = November 2008 | pmid = 19001437 | doi = 10.1158/1535-7163.MCT-08-0569 | url = http://mct.aacrjournals.org/cgi/pmidlookup?view=long&pmid=19001437 }}</ref>
Recently, a new more selective GLUT1 inhibitor, Bay-876, has been described.
==Interactive pathway map==
|